ZA829335B - Pharmaceutical preparation for treating alzheimer's disease - Google Patents

Pharmaceutical preparation for treating alzheimer's disease

Info

Publication number
ZA829335B
ZA829335B ZA829335A ZA829335A ZA829335B ZA 829335 B ZA829335 B ZA 829335B ZA 829335 A ZA829335 A ZA 829335A ZA 829335 A ZA829335 A ZA 829335A ZA 829335 B ZA829335 B ZA 829335B
Authority
ZA
South Africa
Prior art keywords
disease
pharmaceutical preparation
treating alzheimer
alzheimer
treating
Prior art date
Application number
ZA829335A
Other languages
English (en)
Inventor
Donald Raymond Mclachlan
Original Assignee
Mclachlan Donald Raymond Prof
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mclachlan Donald Raymond Prof filed Critical Mclachlan Donald Raymond Prof
Publication of ZA829335B publication Critical patent/ZA829335B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA829335A 1981-12-21 1982-12-20 Pharmaceutical preparation for treating alzheimer's disease ZA829335B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/332,794 US4419365A (en) 1981-12-21 1981-12-21 Method of treating Alzheimer's disease

Publications (1)

Publication Number Publication Date
ZA829335B true ZA829335B (en) 1983-09-28

Family

ID=54774394

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA829335A ZA829335B (en) 1981-12-21 1982-12-20 Pharmaceutical preparation for treating alzheimer's disease

Country Status (6)

Country Link
US (1) US4419365A (xx)
JP (1) JPS58121213A (xx)
BE (1) BE895406A (xx)
DE (1) DE3247062A1 (xx)
IT (1) IT1155241B (xx)
ZA (1) ZA829335B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
AU596791B2 (en) * 1984-12-19 1990-05-17 Ciba-Geigy Ag New carbonic acid esters
US5217998A (en) * 1985-07-02 1993-06-08 Biomedical Frontiers, Inc. Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
EP0214101A3 (de) * 1985-09-03 1989-05-31 Ciba-Geigy Ag Verwendung von Eisen(III)-Chelatoren vom Typ Desferrioxamin B und Desferriferrithiocin zur Behandlung von Malaria
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4599361A (en) * 1985-09-10 1986-07-08 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4698431A (en) * 1985-11-12 1987-10-06 The United States Of America As Represented By The United States Department Of Energy Hydroxypyridonate chelating agents
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
US4897388A (en) * 1988-12-20 1990-01-30 Geriatric Research Institute, Inc. Method of treating Alzheimer's disease
US5023784A (en) * 1989-04-06 1991-06-11 Doral Technical Services, Inc. Method for diagnosing serum deficiencies
US5158979A (en) * 1989-04-19 1992-10-27 New York University Method and compositions for treating pneumocystic carini infections
US5268165A (en) * 1990-10-16 1993-12-07 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
DE69227380T3 (de) * 1991-11-12 2007-01-11 Prana Biotechnology Ltd., South Melbourne Verfahren zur bestimmung und behandlung von alzheimer-krankheit
HU214452B (hu) * 1992-06-01 1998-03-30 BIOGAL Gyógyszergyár Rt. Eljárás nagytisztaságú deferoxamin-B-sók előállítására
GB9211779D0 (en) * 1992-06-03 1992-07-15 Ciba Geigy Ag Amine salts
TW274630B (xx) * 1994-01-28 1996-04-21 Wako Zunyaku Kogyo Kk
JPH0925234A (ja) * 1995-07-12 1997-01-28 Wakunaga Pharmaceut Co Ltd 脳疾患改善剤
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
US6780852B2 (en) 1997-12-09 2004-08-24 Bo E. Hedlund Modified polysaccharides exhibiting altered biological recognition
CA2314716C (en) 1997-12-09 2009-02-03 Biomedical Frontiers, Inc. Modified polysaccharides exhibiting altered biological recognition
US20030236224A1 (en) * 1997-12-09 2003-12-25 Hedlund Bo E. Modified polysaccharides exhibiting altered biological recognition
US7189703B2 (en) * 1998-01-09 2007-03-13 Intracell, Llc Treatment and diagnosis of alzheimer's disease
US20050112543A1 (en) * 1998-03-11 2005-05-26 The General Hospital Corporation Method of screening for drugs useful in treating Alzheimer's disease
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
US6946453B2 (en) 1998-11-18 2005-09-20 Collagenex Pharmaceuticals, Inc. 4-dedimethylaminotracycline derivatives
US6506740B1 (en) 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
DE10262084B4 (de) 2002-05-17 2009-12-24 Dr. Franz Köhler Chemie GmbH Protektive Lösung zur Verhinderung von Ischämieschäden
US7728038B2 (en) * 2004-08-04 2010-06-01 University Of Utah Research Foundation Methods for chelation therapy
EP3795171B1 (en) 2014-07-11 2024-04-10 Grifols Worldwide Operations Limited Transferrin for use in kidney transplantation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1898E (fr) 1903-04-01 1903-11-07 Louis Galland Concasseur à machoires multiples
DE1123436B (de) 1959-09-25 1962-02-08 Ciba Geigy Verfahren zur Herstellung neuer Wuchsstoffe
DK103564C (da) 1960-10-11 1966-01-24 Ciba Geigy Fremgangsmåde til fremstilling af trihydroxamsyrer eller salte eller O-acylderivater deraf.
FR1315046A (fr) 1960-10-11 1963-01-18 Ciba Geigy Procédé de préparation d'acides trihydroxamiques à longue chaîne et de leurs composés complexes

Also Published As

Publication number Publication date
JPH0318602B2 (xx) 1991-03-13
DE3247062C2 (xx) 1993-07-01
BE895406A (fr) 1983-06-20
US4419365A (en) 1983-12-06
IT8249698A0 (it) 1982-12-20
DE3247062A1 (de) 1983-07-07
IT1155241B (it) 1987-01-21
JPS58121213A (ja) 1983-07-19

Similar Documents

Publication Publication Date Title
ZA829335B (en) Pharmaceutical preparation for treating alzheimer's disease
DE3269625D1 (en) Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and the compounds for therapeutical use
EP0541686A4 (en) Tachykinin agonists for treatment of alzheimer's disease
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
GB2107214B (en) Pharmaceutical excipients
AR243180A1 (es) Procedimiento para la obtencion de 3,4-dihidro-2h-benzopiranos sustituidos.
HK53188A (en) Pharmaceutical formulations
HU906302D0 (en) Process for producing 3'azido-purine-nucleosides and pharmaceutical preparatives containing these compounds
PT75209A (fr) Procede de preparation d'amidobenzamides
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
RO83114B (ro) Procedeu pentru prepararea ditiazolil-(2, 2')-disulfurilor
FR2630735B1 (fr) Procede de preparations d'halogenophenols
EP0389110A3 (en) Process for the preparation of 2'-deoxy-5-trifluoromethyl-beta-uridine
EP0297296A3 (en) Process for the preparation of 2,2'-oxybisûn,n-dimethyl-ethylamine¨
FR2633273B1 (fr) Procede de preparation de tetraflurorure d'uranium
EP0078533A3 (en) Medicinal composition for treating skin disorders
DE3261303D1 (en) Process for the preparation of 4,4'-dibenzoylamino dianthrimide carbazole
DE3265284D1 (en) Process for the preparation of 3,5-dimethylphenol
EP0081461A3 (en) Imidazobenzodiazepines, process for their preparation, pharmaceutical preparations containing these compounds and their therapeutical use
ZA822120B (en) Pharmaceutical preparation
GB8728036D0 (en) Therapy for alzheimer's disease
PT74968B (fr) Procede pour la preparation d'une vaccin contre les brucelloses humaines
GB8925512D0 (en) Therapy for alzheimer's disease
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
FR2615850B1 (fr) Procede de preparation de tetrafluorure d'uranium